Page last updated: 2024-11-01

nilutamide and Heart Failure

nilutamide has been researched along with Heart Failure in 1 studies

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research Excerpts

ExcerptRelevanceReference
"Elevated risks of arrhythmia (adjusted HR=1."1.46Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study. ( Cassidy-Bushrow, AE; Haque, R; Keating, NL; Potosky, AL; Tsai, HT; UlcickasYood, M; Van Den Eeden, SK; Xu, X, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haque, R1
UlcickasYood, M1
Xu, X1
Cassidy-Bushrow, AE1
Tsai, HT1
Keating, NL1
Van Den Eeden, SK1
Potosky, AL1

Other Studies

1 other study available for nilutamide and Heart Failure

ArticleYear
Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study.
    British journal of cancer, 2017, Oct-10, Volume: 117, Issue:8

    Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Arrhythmias, Cardiac; Califor

2017